News in the Life Sciences Industry

STOCKHOLM, June 4, 2019 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) announces that the company will participate at the 2019 BIO International Convention in Philadelphia, US. The presentation will take place at 11.30am local time on Wednesday, June 5, 2019. Christina Herder, EVP... Read more ››

LUND, Sweden, June 4, 2019 /PRNewswire/ -- Camurus announces that the leading drug dependence journal Addiction has today published full results from a 48-week, open-label, global Phase 3 study of weekly and monthly Buvidal(®) (prolonged-release buprenorphine), the first and only long-acting... Read more ››

STOCKHOLM, June 3, 2019 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced a 10-year exclusive distribution agreement with the Chinese distributor Kyuan Xinhai Medical, a subsidiary of partly state-owned Shanghai Pharma, the second largest life science company... Read more ››

STOCKHOLM, June 3, 2019 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today informs that new data from the phase I study of birinapant in combination with pembrolizumab (Keytruda®) was presented at an oral session on June 2nd at the American Society of Clinical Oncology (ASCO)... Read more ››

STOCKHOLM, June 3, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO), a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological cancers, announced today new data presented at the the 2019 American Society of Clinical Oncology... Read more ››

TAIPEI, Taiwan, June 3, 2019 /PRNewswire/ -- The Innovation & Incubation Center (IAIC), an arm of the Executive Operation Office for Industry-Academia Cooperation at Chung Yuan Christian University (CYCU) hosted the International Venture Capital Investment Match event on May 27, 2019. Over... Read more ››

STOCKHOLM, June 2, 2019 /PRNewswire/ -- New phase I clinical data on Cantargia´s antibody CAN04 (nidanilimab) were presented today in an oral session at the 2019 ASCO Annual Meeting. Data from 22 patients show that CAN04 treatment has a good safety profile. Most patients treated got a decrease... Read more ››

UPPSALA, Sweden, May 31, 2019 /PRNewswire/ -- The number of votes in Orexo AB has changed as a result of the conversion of 110,029 class C shares into ordinary shares due to vesting under the company's long-term incentive program, LTIP 2016/2019.

LINKÖPING, Sweden, May 30, 2019 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed a... Read more ››

LINKÖPING, Sweden, May 28, 2019 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra... Read more ››

STOCKHOLM, May 28, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that they will attend the Jefferies annual Healthcare Conference in New York between June 4-7th and make a plenum presentation on June 7th 11.30am EST.

STOCKHOLM, May 27, 2019 /PRNewswire/ -- Cantargia's Annual General Meeting on 27 May 2019 resolved in accordance with the following:

STOCKHOLM, May 27, 2019 /PRNewswire/ -- Cantargia AB's ("Cantargia") interim report for first quarter 2019 is now available on the company's web page Read more ››

STOCKHOLM, May 27, 2019 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) announces that the company will participate at the Redeye Pre-ASCO Seminar in Stockholm. The presentation will take place at 9.15am on Tuesday, May 28, 2019. Dr. Uli Hacksell, CEO of Medivir, will present the... Read more ››

UPPSALA, Sweden, May 24, 2019 /PRNewswire/ -- Biotage AB (Biotage), (NASDAQ OMX Stockholm: BIOT.ST) - Biotage has appointed Tomas Blomquist as the new CEO and President of Biotage AB. Tomas Blomquist, most recently Vice President EMEA Cardimetabolic at Abbott, will start his assignment on November... Read more ››